Hepatitis B Virus Seroprevalence

Author Name: Alpine

Category Name: Genetic And Molecular Biology

Description:

Infections caused by Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV) co-infection remain among the top ten most important health problems worldwide. HBV and HIV co-infection is common due to shared routes of transmission, which would modify the progression, manifestation or management of each of the infections.

Although studies have been carried out among blood donors, and HBV genotypes established, this data on the seroprevalence of the co-infection remains insufficient in Kenya. Coupled with genetic diversity that drives disease outcome, there is need to monitor the diversity of HBV especially among HIV patients seeking medical intervention.

 This study intends to determine the seroprevalence and genetic diversity of HBV among HIV infected patients in Nyanza. Remnant plasma samples from Comprehensive Care Clinic (CCC) at Jaramogi Oginga Teaching and Referral Hospital (JOOTRH), Kisumu will be used in this study.

Infections caused by Hepatitis B Virus (HBV) and Human Immunodeficiency Viruses (HIV) remain the leading most important health problems worldwide.

 HBV is among the top 10 leading causes of infectious disease deaths worldwide. Globally, chronic infection with each of these viruses alone contributes to substantial morbidity. HIV infection accounts for an estimated 40 million persons and HBV infection accounts for an estimated 370 million chronic infections .

Submit manuscript -https://www.imedpub.com/submissions/international-journal-case-reports.html

Regards,

Alipine

Managing Editor

Journal of Clinical Microbiology.